Politics, Policy & Law
Biotech CEOs respond to Sanders attack: science, not politics, will defeat the pandemic
Product Development
Phase II data bring Blueprint closer to major market expansion for Ayvakit
Product Development
COVID-19 Roundup: Trial starts for Moderna, Sanofi-Regeneron and BioNTech; plus Thermo Fisher, Roche and VIB
Product Development
Bumpy ride for debut of Verily’s COVID-19 screening platform
Product Development
Teva, Celltrion launch fourth U.S. Herceptin biosimilar at modest discount
Product Development
March 16 Quick Takes: FDA raises efficacy questions for DBV allergy therapy; plus Novo, Provention, UCB, Pfizer-EMD Serono, Zai, AcelRx-Tetraphase, Medivir-Tan
Politics, Policy & Law
Grassley-Wyden drug price bill attacks rebates, includes inflation caps
Management Tracks
CureVac CEO Hoerr takes leave of absence; German biotech rejects reports of U.S. approach for COVID-19 vaccine